The Patent Finder

Tetragenex Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Tetragenex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Tetragenex Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,797,897Timer
Lapsed on the fee record
Ended Sep 28, 2012 · Medium confidence
Lapsed on the fee recordEnded Sep 28, 2012Medium confidence
US 6,767,897Therapeutic uses of tri-, tetra-, penta-, and polypeptides
Lapsed on the fee record
Ended Jul 27, 2012 · USPTO record
Lapsed on the fee recordEnded Jul 27, 2012USPTO record
US 6,093,797Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent
Lapsed on the fee record
Ended Jul 25, 2012 · USPTO record
Lapsed on the fee recordEnded Jul 25, 2012USPTO record
US 7,214,669Tetracycline derivatives and methods of use thereof
Lapsed on the fee record
Ended May 8, 2011 · USPTO record
Lapsed on the fee recordEnded May 8, 2011USPTO record
US 5,589,460Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
Term ended
Term ended no later than Dec 31, 2016 · Low confidence
Term endedTerm ended no later than Dec 31, 2016Low confidence
US 5,721,207Method for treatment of pain
Term ended
Term ended no later than Feb 24, 2018 · Low confidence
Term endedTerm ended no later than Feb 24, 2018Low confidence
US 5,767,083Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
Term ended
Term ended no later than Jun 16, 2018 · Low confidence
Term endedTerm ended no later than Jun 16, 2018Low confidence
US 5,840,683Peptides inhibiting the oncogenic action of p21 ras
Term ended
Term ended no later than Nov 24, 2018 · Low confidence
Term endedTerm ended no later than Nov 24, 2018Low confidence
US 5,910,478Peptidomimetics inhibiting the oncogenic action of p21 ras
Term ended
Term ended no later than Jun 8, 2019 · Low confidence
Term endedTerm ended no later than Jun 8, 2019Low confidence
US 5,990,172Peptidomimetics for the treatment of HIV infection
Term ended
Term ended no later than Nov 23, 2019 · Low confidence
Term endedTerm ended no later than Nov 23, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited